G165R (p.Gly165Arg) variant of PTEN (P60484)

G165R (p.Gly165Arg) in PTEN (P60484) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of PTEN hamartoma tumor syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.92 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.

G165R (p.Gly165Arg) variant details